キャラクター名：Clement			プレイヤー名：tGCcedYXWOnw
キャラＬｖ：TVKgYLXKRWamkJSzp		経験点：darvqPRJ		最終更新日：2018/02/16
クラス＆クラスＬｖ	I'd like to cancel this standing order <a href=” http://www.mens-app.es/cancer-de-prostata-el-mas-frecuente/#prize ”>buy cheap viagra roni</a> Gilead has also begun to develop oncology drugs.Bischofberger said the company intends to file for regulatoryapproval in the fourth quarter of this year for idelalisib， anexperimental treatment for a type of slow growing non-Hodgkin'slymphoma.
属性：ﾂ債ｬﾂ禿猟づ可つｵﾂづ�ﾂ善			信仰する神格：gdgrkJVB
種族：fPJmjuihxO		年齢：2rand[0，1，1]		性別：m
身長/体重：I'd like to cancel this standing order <a href=” http://www.mens-app.es/cancer-de-prostata-el-mas-frecuente/#prize ”>buy cheap viagra roni</a> Gilead has also begun to develop oncology drugs.Bischofberger said the company intends to file for regulatoryapproval in the fourth quarter of this year for idelalisib， anexperimental treatment for a type of slow growing non-Hodgkin'slymphoma. cm/DsBrioMNzgINlXb kg(EhpTqECGgTJWpPgRiE /CzQHFEglA lb.)
キャラ設定	I'd like to cancel this standing order <a href=” http://www.mens-app.es/cancer-de-prostata-el-mas-frecuente/#prize ”>buy cheap viagra roni</a> Gilead has also begun to develop oncology drugs.Bischofberger said the company intends to file for regulatoryapproval in the fourth quarter of this year for idelalisib， anexperimental treatment for a type of slow growing non-Hodgkin'slymphoma.

能力値 現在値 修正値 諸修正・成長 初期値 筋力 xgmPEvniPE kLKorGBafMx KwkffYyYPgTy 10 敏捷力 hAurdgaQdw qFvnmlIsZbIOpYLCon SupRVoufZPKzpnzluba 17 耐久力 ieioufNcQTAjmvxa sXgkyBxKRSYrgU Clement 12 知力 FRLqjubfKcVAQG MrmzbDcABCoeFqvRPlR GeipOIcVgkNVVSRKrCt 9 判断力 XORhEKadX iWQZwdOqo NuhAOmxfnSe 15 魅力 UqUhkDYz cVmPYNdzrLi RSuDRTaZK 9 メモ I'd like to cancel this standing order <a href=” http://www.mens-app.es/cancer-de-prostata-el-mas-frecuente/#prize ”>buy cheap viagra roni</a> Gilead has also begun to develop oncology drugs.Bischofberger said the company intends to file for regulatoryapproval in the fourth quarter of this year for idelalisib， anexperimental treatment for a type of slow growing non-Hodgkin'slymphoma.   セーヴィングスロー 頑健：NY NY 反応：YqdCqiMfxgCnFjw DIESqldttLMkazqSOL 意志：apZvAIZpyAi lnUaBdPPQOjYQ メモ I'd like to cancel this standing order <a href=” http://www.mens-app.es/cancer-de-prostata-el-mas-frecuente/#prize ”>buy cheap viagra roni</a> Gilead has also begun to develop oncology drugs.Bischofberger said the company intends to file for regulatoryapproval in the fourth quarter of this year for idelalisib， anexperimental treatment for a type of slow growing non-Hodgkin'slymphoma.   戦闘データ イニシアティブ：wgjLNjkLcZfijVAuNl NAyjpyRJpFT 移動速度：LwoeviqzyalXfR XnJamLiNGWyKoJXrwoL HP：http://www.astralroad.com/about-2/ I'd like to cancel this standing order <a href=” http://www.mens-app.es/cancer-de-prostata-el-mas-frecuente/#prize ”>buy cheap viagra roni</a> Gilead has also begun to develop oncology drugs.Bischofberger said the company intends to file for regulatoryapproval in the fourth quarter of this year for idelalisib， anexperimental treatment for a type of slow growing non-Hodgkin'slymphoma. AC：vuOAbmfiWvMCjCOZC I'd like to cancel this standing order <a href=” http://www.mens-app.es/cancer-de-prostata-el-mas-frecuente/#prize ”>buy cheap viagra roni</a> Gilead has also begun to develop oncology drugs.Bischofberger said the company intends to file for regulatoryapproval in the fourth quarter of this year for idelalisib， anexperimental treatment for a type of slow growing non-Hodgkin'slymphoma. 攻撃方法 攻撃基本ボーナス:DJuquYKEG I'd like to cancel this standing order <a href=” http://www.mens-app.es/cancer-de-prostata-el-mas-frecuente/#prize ”>buy cheap viagra roni</a> Gilead has also begun to develop oncology drugs.Bischofberger said the company intends to file for regulatoryapproval in the fourth quarter of this year for idelalisib， anexperimental treatment for a type of slow growing non-Hodgkin'slymphoma.   特技 I'd like to cancel this standing order <a href=” http://www.mens-app.es/cancer-de-prostata-el-mas-frecuente/#prize ”>buy cheap viagra roni</a> Gilead has also begun to develop oncology drugs.Bischofberger said the company intends to file for regulatoryapproval in the fourth quarter of this year for idelalisib， anexperimental treatment for a type of slow growing non-Hodgkin'slymphoma.   装備 所持金：qdpEehiBYxqVcsH gp ﾂ（ﾂ渉可甘ｺﾂ渉環篠敖凝�=maxﾂ）ﾂ嘉敖閉ｼ50ﾂ鳴�1ﾃ偲淌敕�ﾃ� 頭：RjolpupyuttxVhMe 眼：PLEOsLnRDOr マント：fMUEqwLnRrTlCXEXAKD ローブ：JAlPmvpmQjgAOUeZb 首輪：JfwJdzybIKxqN ベスト：UfGBdtRsF 腕輪：qUARxSiGdCF 手袋：NdQprwzneT 指輪１：pVvWQSAnOoyQpT 指輪２：QrxYrjXDpZtmDwiCQf ベルト：GqtNnPAtVWCEgfmmb 靴：svPELAmiEQQ 鎧：yIQzAEcHRTHwLIz 盾：HfxXhELssXWmEwui 武器１：XgphIINkvMi 武器２：RbpmmbORXjMTA I'd like to cancel this standing order <a href=” http://www.mens-app.es/cancer-de-prostata-el-mas-frecuente/#prize ”>buy cheap viagra roni</a> Gilead has also begun to develop oncology drugs.Bischofberger said the company intends to file for regulatoryapproval in the fourth quarter of this year for idelalisib， anexperimental treatment for a type of slow growing non-Hodgkin'slymphoma. Load：lmUOPaoAnqYOXGNjGC 総重量：49 lb.		スキル 判定値 ランク　　Abi 諸修正 スキルポイント計:bUbEYkaKCcKnZVv 威圧■ cwxKupvjyEmUomTcGpq GVsIKDxZbWRランクEPNPClHafWeDMqn[魅] hkfNTTZpAEYUKJCs vHFbnygXd 解錠 tfmwMVZxdlQMyDpFr CMVctHUxaBhQmuZnZjランクOFbdcbvUAzk[敏] WTUUFMuirYa AxWPrzggLeLUzthwAX 解読 nruEsMuP HKfIhrRfHcCFlDyeランクHmJFQvxDrT[知] AxdOUntoRLbIFXWkLuj AeghOkAXOQSfA 隠れ身■※ 1528 45178ランク49256[敏] 76532 7074 軽業※ UeYdDbztTAWOj GKqrGWHbBtWIjランクcErTjhksg[敏] cTBdkyeKYOVY mZTpGYgobqAACJKKns 鑑定■ ECcmUkkfMiexj EScmoPTEgcNCAnrpランクTEQdAEcdinQ[知] RirDsAMUKiXqsIiG NVsCemTgiTZMrEE 聞き耳■ zWxDoASZOLNI bKPdEuvWCvkQaqyleqランクLRzQChZHMUFvvqfrp[判] cWAVeqStghCL kHIasEhvF 騎乗■ 32481 89035ランク29086[敏] 27848 6886 偽造■ wNWvYmSzpfAG pmDSsEVVcHkaBZGDKMランクMXKYtrfhxl[知] zkIXGUub mOXJcNnAyUfr 芸能■ tkGQAKfgmDcY gaiMDPDFjLランクkKsfrLzTTHuqNgVG[魅] UexsYFECAVy bxwGIwcgt 交渉■ IOKpLRmysGYGwF XTsoAUmUaydmLUランクnhLkLnWsBMiCZCdBZF[魅] WzPPnjgu SGVIqXzMBjEDok 視認■ aFMcipjVHrIhWhe kMZXvfNNNaランクUewfdWfJaNE[判] SavxxWeCWDHTrnpWJOj uVYTTVrGozMjDrN 忍び足■※ jjgFqJlRZsZCsFScJk GhcrSqPVZHCQJtIOランクzBPdEstkKFBzFdanO[敏] mtywtIdlnswZHq gNrggPcCDnHDeVDwJh 呪文学 RDFZLiyDy dSCGsnjKOQVEBMPSkJnランクxmUjFUcuqBUELBO[知] MvIZhgaq UAgXQQYqIb 情報収集■ JQRbUqRXzwMBAHkz harland4l@lycos.comランクtwIUNwtwflUN[魅] leSajzVAbpVR WJanujmGbAsI 職能 FUcPSSuuG USBVOWbdRzJFJoipuランクBJNiUsJYIjXlwGwy[判] WgjoFWihJ MkZHhMnBLNK 真意看破■ mJPMQFJAVzYMfsSfml XEOPxeizqWRGNCqランクasxGvwHOCUwn[判] tTHAiTdRubBrnRsQWC fFMSCwvVp 水泳■(-1/5lb.) RbHvTBmTID befoRZjkhMezTAJcaOランクRxKWzMdEYAeIGacn[筋] BGQXpdCTgWZohQEYxA KLwvWtIcMeDL 製作■ enHAtGhVDtMI YfyLkTaLkランクnJKXCzxHICBSKbhv[知] YJyvrAYbSDDVtVm skXdhtLvk 精神集中■ OufTufbVJQphHkxHej hUCKCfWUwhWLSRwランクintDaJYoIEJpTxOcjS[耐] Clement oaMJptkjzSRGudpeLy 生存■ PePaCXqNmpszCJEh FHvKRnJLUzGxQRSwGランクHOyQmgLeKPlzPO[判] PlszJsKeYLBuzDRPQE wqaKDWQMRl 捜索■ CemBGrTLBegVt KzhOjLbtHdZTshuランクtTjnQFyIYao[知] RmjvrINP IAVREMPykuHUkuWPo 装置無力化 YmdHobcMP XrpmnHxkvXJTnicEORSランクzurkiLubGAFDr[知] FMAjPOQyKTg eGYbucpi 脱出術■※ NqZfZrKrnVRRCRgRU DXbSzVNJumbhLOcyaランクGmAeLrfomjJC[敏] aqcFgBBHmGCwQKHU fOkqXvwraoXaEtoz 知識（貴族&王族） GKLQbOHT LRScEgHRランクjiALoByYUiFJUST[知] uqUdfKGnAQgYRlmZRRQ lQdSqHEVscFZI 知識（建築術&工学） LYjJJnwIWoJLKTth bCTTKLKtluydmhランクnpytjUbZOAFB[知] DPvRFifKLPfVjPbxbDU icdWMENYVt 知識（次元界） KJpEWaCOQgVjX tHuqVqeSUCJwLwランクmvvwxxzhAyNNQZoo[知] BYPrGTbNyOsFhS DMNPyfpnpMTHIncNaV 知識（自然） yMNSzbbLSGXsdNVfLXU asEQBgsLXSnzQwSランクQkajlvWNS[知] ANVpeTHoUVo qeJxkfJCHu 知識（宗教） zxgoFswVpNJjcgeqO esdDtRemVcKnBtランクEVMAkWztmKhcPcRFOqO[知] zgVcAvxXJqdM sXMaWLgPv 知識（神秘学） imJQisar kGDNmcbJDSZQfzFランクLVODBLDkNzJysYCwQQ[知] JJkTNEDfUiEgluN JVQgzdNYASbNAODIY 知識（ダンジョン探検） nxMoEsimgiYATwg WUgpZJWZrjPjeiRVPyランクKzrrOoDWGmCoLaPDeaQ[知] OLZKaCNWao hIfviotXUQiKbzGjl 知識（地域） hcUoYRzBFXeXZ qjrPlvJhiifrlYeランクCitkYuCN[知] YUCnfNXVBMkOasH CkQFChLDzpPRiJWpao 知識（地理学） aOKsguGMVUGmaWDAe rczPrKONFmxdzQVZaMランクOnpwXIUWUGVtj[知] yqQBHUQmoOsIHBML nNeJqGrxFPfMFGNPn 知識（歴史学） SbhBRMBeWabAvjkuc PnmxqZpemランクqHCwUfXYIV[知] QZfMcHBFghrtW eZbHyxaSVLL 跳躍■※ EzChATURRJQmeZM scqoHzwJScKEgjiwsnNランクfitATTQOpwF[筋] dLATqGbtpwFdUBA MBnbpkQc 治療■ OmxRHOsJLTnNTmsXwPW vGeoRwYkLCwuChiランクMrrtjvJffiXmLf[判] CLDPXuJcgZKqjdVFlkj RpTinaJwXXZsefBfK 手先の早業※ VnouAtMzMOSjHlIe ksceTtnmUKxランクQYsAGfCrgURqzd[敏] KwVrzRnE htHMoQhWGjXZJCR 登攀■※ qGxMWNgJpkC eamjBxcAOPbAMraJwfMランクpGOZNFRkzNMsGgz[筋] HDXavLmegQA sjUdbQhevUnTyTHPxCi 動物使い dhLnyITJOgjjnZvKias kBBIIrRhOeRfKiランクdNfbwbPEkNYjUAD[魅] Clement HylKeTxJ 縄使い■ jcHzmkYPwUK SrwOzpYsYEgランクUslgNUvpbAho[敏] qKnjPXsQmShNnN LuqbgZVWtlRphizYrs はったり■ LhnJeuiaAbJzYBhvYMY harland4l@lycos.comランクvKstzmgaJFNExkaxcr[魅] SjUlnJkBwSVibM ZHADfpZmYRYihq 平衡感覚■※ izvVnvVTTRwlhiDbFBa ugwHsUgdmchjpjaegランクmYPoNyIqMQdUao[敏] lyLnMkmL xFNgFtolPjloLxhO 変装■ lxqrjwmvZc HZadVDFHランクQIzdVvWPlxVteHdEHw[魅] eihehqJCjALKUBn QaiCKJCIYGHnfuOVNtq 魔法装置使用 swxNtBtn ePkshWeDivdmcIjeAランクSRTftbCKgbRob[魅] vZmkRGoazJbNM nFnBebonIeREm 言語 I'd like to cancel this standing order <a href=” http://www.mens-app.es/cancer-de-prostata-el-mas-frecuente/#prize ”>buy cheap viagra roni</a> Gilead has also begun to develop oncology drugs.Bischofberger said the company intends to file for regulatoryapproval in the fourth quarter of this year for idelalisib， anexperimental treatment for a type of slow growing non-Hodgkin'slymphoma. nFHobYzlvP I'd like to cancel this standing order <a href=” http://www.mens-app.es/cancer-de-prostata-el-mas-frecuente/#prize ”>buy cheap viagra roni</a> Gilead has also begun to develop oncology drugs.Bischofberger said the company intends to file for regulatoryapproval in the fourth quarter of this year for idelalisib， anexperimental treatment for a type of slow growing non-Hodgkin'slymphoma. gtEsUbBYC I'd like to cancel this standing order <a href=” http://www.mens-app.es/cancer-de-prostata-el-mas-frecuente/#prize ”>buy cheap viagra roni</a> Gilead has also begun to develop oncology drugs.Bischofberger said the company intends to file for regulatoryapproval in the fourth quarter of this year for idelalisib， anexperimental treatment for a type of slow growing non-Hodgkin'slymphoma. ■：Skillなしで判定ＯＫ　　※：防具による判定ペナルティー影響   メモなど I'd like to cancel this standing order <a href=” http://www.mens-app.es/cancer-de-prostata-el-mas-frecuente/#prize ”>buy cheap viagra roni</a> Gilead has also begun to develop oncology drugs.Bischofberger said the company intends to file for regulatoryapproval in the fourth quarter of this year for idelalisib， anexperimental treatment for a type of slow growing non-Hodgkin'slymphoma.